These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12600440)

  • 1. Barrett's esophagus with high grade dysplasia: surgical results and long-term outcome--an update.
    Tseng EE; Wu TT; Yeo CJ; Heitmiller RF
    J Gastrointest Surg; 2003 Feb; 7(2):164-70; discussion 170-1. PubMed ID: 12600440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy.
    Heitmiller RF; Redmond M; Hamilton SR
    Ann Surg; 1996 Jul; 224(1):66-71. PubMed ID: 8678620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
    Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
    Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of malignant progression in Barrett's esophagus indefinite for dysplasia.
    Ma M; Shroff S; Feldman M; DeMarshall M; Price C; Tierney A; Falk GW
    Dis Esophagus; 2017 Mar; 30(3):1-5. PubMed ID: 28184470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The management of high grade dysplasia and early cancer in Barrett's esophagus. A multidisciplinary problem.
    Rusch VW; Levine DS; Haggitt R; Reid BJ
    Cancer; 1994 Aug; 74(4):1225-9. PubMed ID: 8055442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia.
    Edwards MJ; Gable DR; Lentsch AB; Richardson JD
    Ann Surg; 1996 May; 223(5):585-9; discussion 589-91. PubMed ID: 8651749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance in Barrett's esophagus: an audit of practice.
    Ajumobi A; Bahjri K; Jackson C; Griffin R
    Dig Dis Sci; 2010 Jun; 55(6):1615-21. PubMed ID: 19669878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronology of the Barrett's metaplasia-dysplasia-carcinoma sequence.
    Theisen J; Nigro JJ; DeMeester TR; Peters JH; Gastal OL; Hagen JA; Hashemi M; Bremner CG
    Dis Esophagus; 2004; 17(1):67-70. PubMed ID: 15209744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low prevalence of submucosal invasive carcinoma at esophagectomy for high-grade dysplasia or intramucosal adenocarcinoma in Barrett's esophagus: a 20-year experience.
    Wang VS; Hornick JL; Sepulveda JA; Mauer R; Poneros JM
    Gastrointest Endosc; 2009 Apr; 69(4):777-83. PubMed ID: 19136106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett's esophagus.
    Larghi A; Lightdale CJ; Memeo L; Bhagat G; Okpara N; Rotterdam H
    Gastrointest Endosc; 2005 Jul; 62(1):16-23. PubMed ID: 15990814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barrett's esophagus: a surgical disease.
    Patti MG; Arcerito M; Feo CV; Worth S; De Pinto M; Gibbs VC; Gantert W; Tyrrell D; Ferrell LF; Way LW
    J Gastrointest Surg; 1999; 3(4):397-403; discussion 403-4. PubMed ID: 10482692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of esophagectomy for high-grade dysplasia or cancer found during surveillance for Barrett's esophagus.
    Chang LC; Oelschlager BK; Quiroga E; Parra JD; Mulligan M; Wood DE; Pellegrini CA
    J Gastrointest Surg; 2006 Mar; 10(3):341-6. PubMed ID: 16504878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occult adenocarcinoma after esophagectomy for Barrett's high-grade dysplasia.
    Donnellan F; Harewood GC; Patchett SE
    Gastrointest Endosc; 2010 Feb; 71(2):429. PubMed ID: 20152322
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term survival after esophagectomy for Barrett's adenocarcinoma in endoscopically surveyed and nonsurveyed patients.
    Ferguson MK; Durkin A
    J Gastrointest Surg; 2002; 6(1):29-35; discussion 36. PubMed ID: 11986015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resection for Barrett's mucosa with high-grade dysplasia: implications for prophylactic photodynamic therapy.
    Ferguson MK; Naunheim KS
    J Thorac Cardiovasc Surg; 1997 Nov; 114(5):824-9. PubMed ID: 9375613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors of coexisting cancer in Barrett's high-grade dysplasia.
    Tharavej C; Hagen JA; Peters JH; Portale G; Lipham J; DeMeester SR; Bremner CG; DeMeester TR
    Surg Endosc; 2006 Mar; 20(3):439-43. PubMed ID: 16437272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical management of high-grade dysplasia in Barrett's esophagus.
    Rice TW; Falk GW; Achkar E; Petras RE
    Am J Gastroenterol; 1993 Nov; 88(11):1832-6. PubMed ID: 8237928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.
    Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE
    Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimally invasive esophagectomy for dysplastic Barrett's esophagus.
    Markar SR; Hanna G
    World J Surg; 2015 Mar; 39(3):608-14. PubMed ID: 25145822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study.
    Cameron AJ; Carpenter HA
    Am J Gastroenterol; 1997 Apr; 92(4):586-91. PubMed ID: 9128304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.